OmiGroup tests evidence-linked disease reasoning on Bedrock
OmiGroup says its OmiKG research proof-of-concept uses Amazon Bedrock to extract relationships from biomedical literature and analyse patient-specific pathways. A small blinded expert evaluation found more representative mechanisms than two comparison systems, but also highlighted citation-fidelity work. The system is not a clinical product; supervised pilots and commercial planning remain future steps.